DEPLOYDatabase

Company

Movano Health

Women's-health smart-ring company (NASDAQ: MOVE; CEO John Mastrototaro) of the consumer Evie Ring (general-wellness) + FDA-cleared B2B EvieMED Ring;…

Track Movano HealthGet notified of verified changes
Founded
2018
HQ
Pleasanton, California, USA
Status
renamed Corvex, Inc. (NASDAQ: MOVE) after all-stock reverse merger closed Mar 19 2026; pivoted to AI infrastructure; legacy Movano wearables (Evie Ring) sales paused, healthcare assets divestiture-pending

Funding

$24.0M

Models

1

Deployments

1

Overview

Women's-health smart-ring company (NASDAQ: MOVE; CEO John Mastrototaro) of the consumer Evie Ring (general-wellness) + FDA-cleared B2B EvieMED Ring; financially distressed (going-concern; possible sale).

Reality check

Risk

Going-concern (deficit $160.5M; runway not beyond Q1 2026; possible sale). RE-VERIFY.

Verified record

Verified deployments
1 deployment on file
Active incidents
1 incident on file

DEPLOY Intelligence

Market intelligence for physical AI

Analyst-grade signals, competitive tracking, and investment context across the global physical AI landscape. Launching 2026.

Key facts

Product

Evie Ring (consumer women's-health, general-wellness) + EvieMED Ring (B2B, FDA 510(k) SpO2 cleared Dec 2024).

Stock ticker

NASDAQ: MOVE

CEO

John Mastrototaro

Company type

Women's-health smart-ring company

Data & sources

Company filings

1

Press releases

2

Web sources

2

5 sources backing this record.View all →

Paused

Evie Ring (and EvieMED)

Movano Health (NASDAQ: MOVE; led by chief executive John Mastrototaro) makes the women's-health-focused Evie smart ring, recorded in the biometric form factor, with cycle tracking and women's-health metrics as its editorial differentiator. A load-bearing entity split applies: there are two rings, the consumer Evie Ring, which tracks the menstrual cycle, sleep, energy, heart rate, blood oxygen, and mood as a general-wellness device that is not FDA-cleared, and the separate business-to-business EvieMED Ring, which received an FDA 510(k) clearance for its pulse oximeter and heart rate on December 2, 2024 for clinical trials, remote patient monitoring, and payor and pharma use, with a pivotal study showing accuracy across darker skin tones, so the clearance must not be attributed to the consumer Evie Ring. A significant financial cap-flag is the real risk here: Movano is distressed, with its SEC filings showing going-concern substantial doubt, an accumulated deficit of $160.5 million as of September 30, 2025, cash not sufficient to fund operations beyond the first quarter of 2026 without further capital or a merger, a strategic review and possible sale underway, a one-for-ten reverse stock split in October 2025 to regain NASDAQ compliance, and a $1.5 million bridge loan at an effective rate around 111.6 percent secured by the company's intellectual property that transfers to the lender if a merger fails to close, so the registry records it at commercial maturity but at risk with an active lifecycle and a re-verification flag given the volatile status. A source-drift note: a secondary article cites a stale 2024 cash figure that the SEC filings supersede with the going-concern position, and the company's market-size framing is total-addressable-market language rather than verified revenue.

biometricView model →

Movano Health on the deployment map

Where Movano Health's robots are verified operating. Explore the deployment map by place and type.

Relationships

Explainers

Plain-language answers to the questions people ask about Movano Health, from DEPLOY’s explainer library. Each is written in the language of the question and cross-checked against this registry.

  • What is Movano Health?

    [Movano Health](https://registry.deploy.report/companies/movano-health) is the operating company behind the [Evie Ring](https://registry.deploy.report/models/movano-evie-ring), a smart ring biometric positioned within the biometric cluster's ring sub-cohort. Per registry verification: company operates as Movano Health; Evie Ring is the consumer-shipped product; per [consumer surface](https://deploy.report/price/movano-evie-ring) the ring operates at consumer retail pricing tier. CRITICAL CORPORATE-STATE-SHIFT CAP-FLAG: per registry references to Corvex + reverse merger, Movano Health operates within a corporate-state-shift via reverse merger structure (verified per registry framing); specific reverse-merger mechanics + timing + post-merger entity scope + Corvex Software corporate-state-shift framing operate at lower verification posture pending primary-source confirmation. Per [DEPLOY's biometric cluster framework](/explainers/biometric), Movano Health Evie Ring operates within the ring sub-cohort alongside Oura + Whoop + RingConn + Ultrahuman + Happy Ring; specific ring-sub-cohort archetype positioning (FDA-clearance posture + subscription-model + commercial-deployment maturity) cap-flagged pending primary-source verification of Movano-specific claim depth.

Current leadership (1)

Safety record

1 incident on record (1 minor). Most recent: Jun 2026.

minor
1

Most recent: Jun 2026

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Full safety record: incidents, sourcing, and exposure data →

Incidents affecting Movano Health (1)

Includes incidents linked directly to this company, to its models, or to deployments of its models or under its operation. Retracted incidents are excluded from this view but remain reachable at their canonical URLs.

Operated deployments (1)

Operator customers (1)

Recent coverage

Movano Health in third-party press

Peer companies